Trump administration unveils plan to allow drug imports from Canada

Listen
Text
  • Small
  • Medium
  • Large

The Trump administration unveiled a plan July 31 that would allow the U.S. to import drugs from Canada, according to The Hill. 

Under most instances, it is illegal to import medications from other countries for personal use in the U.S. The president's plan aims to change the legality of importation from Canada "so the American people get the benefit of the deals that pharma themselves are striking with other countries," HHS Secretary Alex Azar told CNBC. 

HHS outlined several steps it will take to implement the plan, including issuing a regulation to allow states and pharmacies to submit drug importation pilot programs for approval.

Supporters of drug importation say it would increase competition and lower prices. Critics argue that it could threaten consumer safety or reduce drug supplies for Canadians. 

Access the full report here

Editor's Note: This article was updated at 9:30 a.m. July 31.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars